This Article Full Text Full Text (PDF) All Versions of this Article: 36/4/737    most recent 01.STR.0000157598.02014.37v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Slowik, A. Articles by Szczudlik, A. Search for Related Content PubMed PubMed Citation Articles by Slowik, A. Articles by Szczudlik, A. Related Collections Clinical genetics Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Genetics of Stroke

(Stroke. 2005;36:737.)
© 2005 American Heart Association, Inc.

Original Contributions

₁-Antichymotrypsin Gene (SERPINA3) A/T Polymorphism as a Risk Factor for Aneurysmal Subarachnoid Hemorrhage

Agnieszka Slowik, MD; Anna Borratynska, MD; Wojciech Turaj, MD; Joanna Pera, MD; Tomasz Dziedzic, MD; Denise A. Figlewicz, PhD; Marek Betlej, MD; Tadeusz Krzyszkowski, MD; Ryszard Czepko, PhD Andrzej Szczudlik, PhD

From the Departments of Neurology (A. Slowik, A.B., W.T., J.P., A.T.D., A. Szczudlik) and Neurosurgery (M.B., T.K., R.C.), Jagiellonian University, Krakow, Poland; and the Department of Neurology (D.A.F.), University of Michigan, Ann Arbor.

Correspondence to Agnieszka Slowik, MD, Department of Neurology, Jagiellonian University 31-503 Krakow, Botaniczna 3, Poland. E-mail slowik{at}neuro.cm-uj.krakow.pl

Background and Purpose— The member 3 of clade A of serine proteinase inhibitors (SERPINA3), known previously as the ₁-antichymotrypsin, is an acute phase protein, the levels of which increase in acute and chronic inflammation. The A/T polymorphism of the SERPINA3 gene influences expression of SERPINA3 protein. SERPINA3 can be related to aneurysmal subarachnoid hemorrhage (SAH) by influencing inflammation or by regulating cathepsin G activity. We studied the significance of SERPINA3 A/T polymorphism in patients with aneurysmal SAH compared with healthy controls.

Methods— A total of 180 patients with aneurysmal SAH and 263 healthy controls were genotyped for the SERPINA3 A/T polymorphism. Aneurysmal SAH was diagnosed by cranial computed tomography or lumbar puncture and digital subtraction angiography. SERPINA3 polymorphism was detected by polymerase chain reaction amplification and restriction enzyme digestion.

Results— The SERPINA3 genotype distribution in patients with aneurysmal SAH (AA-29 16.1%; AT-108 60.0%; TT-43 23.9%) differed significantly from controls (AA-70 26.6%; AT-123 46.8%; TT-70 26.6%; P=0.009). A logistic regression model showed that the presence of genotype with T allele (AT+TT; odds ratio [OR], 2.01; 95% CI, 1.19 to 3.38; P=0.009) or AA genotype (OR, 0.49; 95% CI, 0.30 to 0.84; P=0.009) of the SERPINA3 influences the risk for aneurysmal SAH independently from smoking, excessive alcohol consumption, and hypertension.

Conclusion— The A/T polymorphism of SERPINA3 gene is associated with the risk factor for aneurysmal SAH.

Key Words: alpha 1-antichymotrypsin • polymorphism • SERPINA3 • subarachnoid hemorrhage